TCR-ligand dissociation rate is a robust and stable biomarker of CD8+ T cell potency.

Allard, Mathilde; Couturaud, Barbara; Carretero-Iglesia, Laura; Duong, Minh Ngoc; Schmidt, Julien; Monnot, Gwennaëlle C; Romero, Pedro; Speiser, Daniel E; Hebeisen, Michael; Rufer, Nathalie.

Afiliación

Allard M; Department of Oncology, Lausanne University Hospital Center (CHUV) and University of Lausanne, Epalinges, Switzerland.
Couturaud B; Department of Oncology, Lausanne University Hospital Center (CHUV) and University of Lausanne, Epalinges, Switzerland.
Carretero-Iglesia L; Department of Oncology, Lausanne University Hospital Center (CHUV) and University of Lausanne, Epalinges, Switzerland.
Duong MN; Department of Oncology, Lausanne University Hospital Center (CHUV) and University of Lausanne, Epalinges, Switzerland.
Schmidt J; Ludwig Cancer Research, University of Lausanne, Epalinges, Switzerland.
Monnot GC; Ludwig Cancer Research, University of Lausanne, Epalinges, Switzerland.
Romero P; Ludwig Cancer Research, University of Lausanne, Epalinges, Switzerland.
Speiser DE; Department of Oncology, Lausanne University Hospital Center (CHUV) and University of Lausanne, Epalinges, Switzerland.
Hebeisen M; Ludwig Cancer Research, University of Lausanne, Epalinges, Switzerland.
Rufer N; Department of Oncology, Lausanne University Hospital Center (CHUV) and University of Lausanne, Epalinges, Switzerland.